Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

The Freezor Cardiac Cryoablation Catheters

FDA expands two Medtronic cardiac cryoablation catheters for AVNRT

The two single-use devices are now approved for the treatment of pediatric AVNRT.

4 new medications and technologies that could transform cardiology in 2022

The FDA has already approved one of the medications, with a decision on another expected by the end of April. 

AstraZeneca COVID-19 vaccine slightly increases risk of blood clots

Researchers emphasized that the benefits of the vaccine still far outweigh the risks. 

A dedicated Cardiac MRI scanner. The presence of myocardial fibrosis on cardiac MRI can help anticipate adverse arrhythmic events and  may offer a way to improve patient selection for cardiac implantable electronic devices (CIEDs). This is a dedicated cardiac MRI system at Baylor Scott White.

Cardiac MRI a powerful tool for predicting sudden cardiac death, arrhythmia after CIED implantation

The study's authors suspect their findings could improve patient selection for CIEDs. 

Unreliable? 76% of world’s blood pressure monitors have not been validated

Researchers examined data on more than 3,400 BP devices used all over the world. A significant majority of them were never clinically validated for accuracy. 

healthcare value value-based care money dollar

Boston Scientific finalizes acquisition of Baylis Medical with $1.75B payment

The deal, first announced in October 2021, expands Boston Scientific’s structural heart disease and electrophysiology portfolios by a significant margin. 

With patient safety slipping, CDC and CMS turn focus to more resilient approaches

COVID-19 has led to a quick and steep decline in patient safety across the entire American healthcare system.

Ticagrelor alone after DAPT lowers bleeding risk among heart attack patients undergoing PCI

Researchers examined data from the TWILIGHT study to track how different treatment strategies can impact 12-month PCI outcomes.